Rudersdal Fodklinik ApS, Statsautoriseret Fodterapeut

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2018
2019/6
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  19.1% 9.9% 13.5% 12.4% 11.9%  
Credit score (0-100)  7 26 17 18 19  
Credit rating  B BB BB BB BB  
Credit limit (kDKK)  -0.0 -0.0 -0.0 -0.0 -0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2018
2019/6
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6

Net sales  0 0 0 0 0  
Gross profit  -299 -1.8 70.3 148 265  
EBITDA  -861 -346 -173 -116 -33.9  
EBIT  -958 -444 -271 -194 -82.3  
Pre-tax profit (PTP)  -999.6 -446.2 -272.4 -194.8 -82.4  
Net earnings  -999.6 -446.2 -272.4 -194.8 -82.4  
Pre-tax profit without non-rec. items  -1,031 -446 -272 -195 -82.4  

 
See the entire income statement

Balance sheet (kDKK) 
2018
2019/6
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6

Tangible assets total  391 293 196 48.4 0.0  
Shareholders equity total  -950 -1,396 -1,668 -1,863 -1,945  
Interest-bearing liabilities  1,895 2,013 2,012 2,009 2,020  
Balance sheet total (assets)  810 649 395 165 91.5  

Net Debt  1,518 1,700 1,855 1,935 1,971  
 
See the entire balance sheet

Volume 
2018
2019/6
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  -299 -1.8 70.3 148 265  
Gross profit growth  0.0% 99.4% 0.0% 109.8% 79.6%  
Employees  1 1 1 1 1  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  810 649 395 165 92  
Balance sheet change%  0.0% -19.8% -39.1% -58.3% -44.4%  
Added value  -861.0 -346.2 -173.3 -96.2 -33.9  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  294 -195 -195 -225 -97  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  -1.0 -2.0 -3.0 -4.0 -5.0  

Profitability 
2018
2019/6
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  320.7% 25,048.6% -385.0% -131.3% -31.0%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  -54.4% -23.3% -13.2% -9.5% -4.0%  
ROI %  -56.0% -23.8% -13.4% -9.6% -4.1%  
ROE %  -123.5% -61.2% -52.2% -69.6% -64.4%  

Solidity 
2018
2019/6
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
Equity ratio %  -54.2% -68.4% -81.3% -92.2% -95.8%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -176.3% -491.0% -1,070.8% -1,664.8% -5,811.7%  
Gearing %  -199.6% -144.2% -120.6% -107.9% -103.8%  
Net interest  0 0 0 0 0  
Financing costs %  7.8% 0.1% 0.1% 0.1% 0.0%  

Liquidity 
2018
2019/6
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
Quick Ratio  1.7 11.7 3.5 4.3 1.6  
Current Ratio  1.6 9.7 2.8 3.1 1.3  
Cash and cash equivalent  376.5 313.5 157.2 74.1 49.4  

Capital use efficiency 
2018
2019/6
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  144.7 281.3 102.0 50.7 12.4  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2018
2019/6
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
Net sales / employee  0 0 0 0 0  
Added value / employee  -861 -346 -173 -96 -34  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  -861 -346 -173 -116 -34  
EBIT / employee  -958 -444 -271 -194 -82  
Net earnings / employee  -1,000 -446 -272 -195 -82